The Ministry makes Official Information Act (OIA) responses available where the information is considered to be of public interest, and where there is no risk to the privacy of individuals. The names and contact details of requestors are removed before publication.
To find out more about making an OIA request, visit OIA requests, where you can make a request via the online tool. Alternatively you can email the OIA Services team.
Documents are usually available in Adobe PDF format only.
| Publication date | Response date | Details of the request | Download |
|---|---|---|---|
| 01 February 2023 | 27 January 2023 | Information regarding COVID-19 vaccine efficacy | H2022018675 response (pdf, 212 KB) |
| 01 February 2023 | 27 January 2023 | Information regarding emergency department waiting times |
H2022018291 response (pdf, 6.1 MB) H2022018291 - Appendix 2 (xlsx, 51 KB) |
| 01 February 2023 | 27 January 2023 | Information related to Principal Advisors at Manatū Hauora | H2023018988 response (pdf, 2.3 MB) |
| 01 February 2023 | 26 January 2023 | Information regarding drinking water data |
H2022018821 response (pdf, 228 KB) H2022018821 - Appendix 1 (xlsx, 245 KB) |
| 01 February 2023 | 25 January 2023 | Information regarding face masks | H2022018342 response (pdf, 277 KB) |
| 01 February 2023 | 24 January 2023 | Information regarding guidelines for COVID-19 vaccination of children | H2022018201 response (pdf, 225 KB) |
| 24 January 2023 | 18 January 2023 | Information related to the COVID-19 vaccine | H2022018490 response (pdf, 1.7 MB) |
| 24 January 2023 | 18 January 2023 | Information related to the International Health Regulations (IHR) | H2022015383 response (pdf, 23.5 MB) |
| 24 January 2023 | 17 January 2023 | Information on the COVID-19 vaccine, testing and response budget | H2022018361 response (pdf, 220 KB) |
| 24 January 2023 | 16 January 2023 | Information on Pfizer Cumulative Analysis Report of PF-07302048 | H2022018890 response (pdf, 194 KB) |
| 24 January 2023 | 16 January 2023 | Information on the classification of cannabidiol | H2022017633 response (pdf, 178 KB) |
| 24 January 2023 | 16 January 2023 | Information on the Focus Group meetings for NEAC | H2022017383 response (pdf, 8 MB) |
| 24 January 2023 | 16 January 2023 | Information regarding staffing at Manatū Hauora | H2022017774 response (pdf, 234 KB) |
| 24 January 2023 | 30 November 2022 | Information on the regulatory impact statement on regulating natural health products |
H2022016152 response (pdf, 211 KB) H2022017883 response (pdf, 2.2 MB) H2022017883 follow up response (pdf, 222 KB) |
| 16 January 2023 | 13 January 2023 | Information on cannabidiol & tetrahydrocannabinol products | H2022017793 response (pdf, 196 KB) |
| 16 January 2023 | 13 January 2023 | Information on end-of-year functions at Manatū Hauora | H2022017746 response (pdf, 255 KB) |
| 16 January 2023 | 12 January 2023 | Information on social media management at Manatū Hauora | H2022017765 response (pdf, 203 KB) |
| 16 January 2023 | 12 January 2023 | Information regarding the Pfizer COVID-19 vaccine | H2022018097 response (pdf, 177 KB) |
| 16 January 2023 | 12 January 2023 | Information relating to antimicrobial resistance in fungal organisms | H2022017744 response (pdf, 232 KB) |
| 16 January 2023 | 11 January 2023 | Information on the communications team at Manatū Hauora | H2022017745 response (pdf, 218 KB) |
| 16 January 2023 | 11 January 2023 | Information regarding amendments to the Mental Health Act | H2022017874 response (pdf, 2.4 MB) |
| 16 January 2023 | 11 January 2023 | Information regarding the Pfizer COVID-19 vaccine | H2022018695 response (pdf, 143 KB) |
| 16 January 2023 | 09 January 2023 | Information regarding psychoactive substance licenses | H2022017627 response (pdf, 177 KB) |
| 16 January 2023 | 23 December 2022 | Information on working from home policy at Manatū Hauora | H2022017741 response (pdf, 225 KB) |
| 16 January 2023 | 23 December 2022 | Information regarding Manatū Hauora employee statistics | H2022017605 response (pdf, 296 KB) |